Pharma's Almanac: Nice Insight's Content Community

FUJIFILM

1 / 1

Facility Acquisition

Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

Fujifilm Diosynth Biotechnologies

PR-M04-22-01Apr 04, 2022

Facility Acquisition

Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

Fujifilm Diosynth Biotechnologies

PR-M01-22-18Jan 26, 2022

Strategic Alliance

FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce Strategic Alliance to Improve the Drug Discovery Process

FUJIFILM

PR-M01-22-05Jan 06, 2022

Partnership

Fujifilm Partners with Dr. Reddy's and Global Response Aid for Deployment of a COVID-19 Treatment Drug Outside of Japan

Nice Insight

PR-M06-20-NI-043Jul 02, 2020

Liposome Formulations

FUJIFILM Toyama Chemical Announces Completion of Japan’s First Manufacturing Facility for Commercial Liposome Formulations

FUJIFILM Toyama Chemical

PR-M12-19-NI-015Dec 10, 2019

Partnership

Fujifilm Expands RIS Revenue Cycle Solutions With Availity Partnership

FUJIFILM

PR-M06-18-NI-033Jun 12, 2018

Viral Vector

Flexible, Mobile, Modular: High-Containment Viral Vector Center of Excellence

Thomas Page, Ph.D.

Fujifilm Diosynth Biotechnologies

PAP-Q2-18-CL-005May 29, 2018

Expansion

Fujifilm Announces The Expansion Of Its Fill Finish Services

Fujifilm Diosynth Biotechnologies

PR-M05-18-NI-095May 25, 2018

Acquistion

FUJIFILM Expands into Bio-Medical Business with Acquisition

Marc Technow

Nice Insight

PR-M03-18-NI-103Mar 30, 2018

Imaging

Fujifilm Debuts ASPIRE Bellus II, A New Multimodality Mammography Workstation

FUJIFILM

PR-M03-18-NI-041Mar 12, 2018

Investment

FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.

Nice Insight

PAO-M11-17-NI-029Nov 17, 2017

1 / 1